1. Home
  2. FA vs LIVN Comparison

FA vs LIVN Comparison

Compare FA & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Advantage Corporation

FA

First Advantage Corporation

HOLD

Current Price

$20.69

Market Cap

4.1B

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$78.26

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FA
LIVN
Founded
2003
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.5B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
FA
LIVN
Price
$20.69
$78.26
Analyst Decision
Buy
Buy
Analyst Count
4
7
Target Price
$15.67
$72.43
AVG Volume (30 Days)
2.5M
660.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
72.97
N/A
EPS
0.11
2.33
Revenue
$1,574,389,000.00
N/A
Revenue This Year
$8.42
$9.79
Revenue Next Year
$7.26
$6.63
P/E Ratio
$190.00
$33.79
Revenue Growth
83.02
N/A
52 Week Low
$8.82
$48.82
52 Week High
$25.15
$85.76

Technical Indicators

Market Signals
Indicator
FA
LIVN
Relative Strength Index (RSI) 48.63 46.77
Support Level $19.05 $74.99
Resistance Level $21.42 $81.83
Average True Range (ATR) 1.07 2.68
MACD -0.23 -0.17
Stochastic Oscillator 11.20 49.81

Price Performance

Historical Comparison
FA
LIVN

About FA First Advantage Corporation

First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: